SightfileU.S. market data from official filings

MINIMED GROUP INC (MMED)

Name: MINIMED GROUP INC (MMED) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0002062583 · EDGAR filings · Updated 2026-07-06

MINIMED GROUP INC (MMED) has reported institutional ownership of 11.6%, with 57 institutional managers holding positions valued at $484.4M per the latest 13F reporting period.

Institutional ownership

11.6%

Institutional managers

Reported 13F value

$484.4M

Insider activity

34 trans.

$0 net flat

Latest updates

2026-07-06 — Initial insider ownership filed (Form 3)
2026-07-06 — Initial insider ownership filed (Form 3)
2026-07-06 — Insider transaction reported (Form 4)
2026-07-06 — Insider transaction reported (Form 4)
2026-07-06 — Insider transaction reported (Form 4)
2026-07-06 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, MINIMED GROUP INC has 57 institutional holders and institutional ownership of 11.6%.

Insider activity

Insiders reported 34 transactions (0 buys, 0 sells) across 11 reporting insiders, with a net reported value of $0.

Related companies

COMPASS PATHWAYS ADR A FUNSPONSORED ADR 1 ADR REPS 1 ORD SHS (CMPS) · MAPLIGHT THERAPEUTICS INC (MPLT) · BETA BIONICS INC (BBNX) · SANA BIOTECHNOLOGY INC (SANA) · 4D MOLECULAR THERAPEUTICS IN (FDMT) · BIOVENTUS (BVS)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-06.